Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect

References

• BrowderTButterfieldCEKralingBMAntiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancerCancer Res20006071878188610766175
   PubMed Web of Science ®Google Scholar
• KerbelRSKamenBAThe anti-angiogenic basis of metronomic chemotherapyNat Rev Cancer20044642343615170445
   PubMed Web of Science ®Google Scholar
• MalikPSRainaVAndreNMetronomics as maintenance treatment in oncology: time for chemo-switchFront Oncol201441724478982
   PubMedGoogle Scholar
• SorianoJLBatistaNSantiestebanEMetronomic cyclophosphamide and methotrexate chemotherapy combined with 1E10 anti-idiotype vaccine in metastatic breast cancerInt J Breast Cancer2011201116
   Google Scholar
• ThankiKGangwalRPSangamwarATJainSOral delivery of anticancer drugs: challenges and opportunitiesJ Control Release20131701154023648832
   PubMed Web of Science ®Google Scholar
• DeVitaVTJrChuEA history of cancer chemotherapyCancer Res200868218643865318974103
   PubMed Web of Science ®Google Scholar
• DengLDongHDongAZhangJA strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activityEur J Pharm Biopharm201597Pt A10711726515259
   PubMedGoogle Scholar
• ShinSCChoiJSLiXEnhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in ratsInt J Pharm20063131–214414916516418
   PubMedGoogle Scholar
• KuppensIEBoschTMvan MaanenMJOral bioavailability of docetaxel in combination with OC144-093 (ONT-093)Cancer Chemother Pharmacol2005551727815316750
   PubMed Web of Science ®Google Scholar
• AdjeiAAPharmacology and mechanism of action of pemetrexedClin Lung Cancer20045S51S5515117425
   PubMedGoogle Scholar
• HanauskeARChenVPaolettiPNiyikizaCPemetrexed disodium: a novel antifolate clinically active against multiple solid tumorsOncologist20016436337311524555
   PubMed Web of Science ®Google Scholar
• RussoFBearzAPampaloniGInvestigators of Italian Pemetrexed Monotherapy of NSCLC GroupPemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancerBMC Cancer2008821618667090
   PubMed Web of Science ®Google Scholar
• FuldADDragnevKHRigasJRPemetrexed in advanced non-small-cell lung cancerExpert Opin Pharmacother20101181387140220446853
   PubMed Web of Science ®Google Scholar
• TomasiniPBarlesiFMascauxCGreillierLPemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomesTher Adv Med Oncol20168319820827239238
   PubMed Web of Science ®Google Scholar
• LalRHillerdalGNShahRNFeasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancerLung Cancer201589215416026101013
   PubMed Web of Science ®Google Scholar
• AungstBJAbsorption enhancers: applications and advancesAAPS J2012141101822105442
   PubMed Web of Science ®Google Scholar
• BansalTAkhtarNJaggiMKharRKTalegaonkarSNovel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulationDrug Discov Today20091421–221067107419647803
   PubMed Web of Science ®Google Scholar
• TianCAsgharSWuYImproving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriersInt J Nanomed20171278977911
   PubMed Web of Science ®Google Scholar
• KalepuSManthinaMPadavalaVOral lipid-based drug delivery systems – an overviewActa Pharmaceutica Sinica B201336361372
   Web of Science ®Google Scholar
• GuanPLuYQiJEnhanced oral bioavailability of cyclosporine A by liposomes containing a bile saltInt J Nanomed20116965974
   PubMed Web of Science ®Google Scholar
• DianLYuEChenXEnhancing oral bioavailability of quercetin using novel soluplus polymeric micellesNanoscale Res Lett20149111124380376
   PubMed Web of Science ®Google Scholar
• SigwardEMignetNRatPFormulation and cytotoxicity evaluation of new self-emulsifying multiple W/O/W nanoemulsionsInt J Nanomedicine2013861162523403891
   PubMed Web of Science ®Google Scholar
• JoshiGKumarASawantKEnhanced bioavailability and intestinal uptake of gemcitabine HCl loaded PLGA nanoparticles after oral deliveryEur J Pharm Sci201460808924810394
   PubMed Web of Science ®Google Scholar
• KimJEYoonISChoHJKimDHChoiYHKimDDEmulsion-based colloidal nanosystems for oral delivery of doxorubicin: improved intestinal paracellular absorption and alleviated cardiotoxicityInt J Pharm2014464111712624463005
   PubMedGoogle Scholar
• YenCCChenYCWuMTWangCCWuYTNanoemulsion as a strategy for improving the oral bioavailability and anti-inflammatory activity of andrographolideInt J Nanomedicine20181366968029440893
   PubMed Web of Science ®Google Scholar
• SoniKMujtabaAKohliKLipid drug conjugate nanoparticle as a potential nanocarrier for the oral delivery of pemetrexed diacid: formulation design, characterization, ex vivo, and in vivo assessmentInt J Biol Macromol201710313915128499946
   PubMed Web of Science ®Google Scholar
• RezhdoOSpecinerLCarrierRLipid-associated oral delivery: mechanisms and analysis of oral absorption enhancementJ Control Release201624054456027520734
   PubMed Web of Science ®Google Scholar
• ParkJWKimSJKwagDSMultifunctional delivery systems for advanced oral uptake of peptide/protein drugsCurr Pharm Des201521223097311026027575
   PubMed Web of Science ®Google Scholar
• MahmudFJeonOCAl-HilalTAAbsorption mechanism of a physical complex of monomeric insulin and deoxycholyl-l-lysyl-methylester in the small intestineMol Pharm20151261911192025892399
   PubMedGoogle Scholar
• JeonOCByunYParkJWPreparation of oxaliplatin-deoxycholic acid derivative nanocomplexes and in vivo evaluation of their oral absorption and tumor growth suppressionJ Nanosci Nanotechnol20161622061206427433728
   PubMed Web of Science ®Google Scholar
• JeonOCSeoDHKimHSByunYParkJWOral delivery of zoledronic acid by non-covalent conjugation with lysine-deoxycholic acid: in vitro characterization and in vivo anti-osteoporotic efficacy in ovariectomized ratsEur J Pharm Sci20168211026542347
   PubMed Web of Science ®Google Scholar
• SunSLiangNKawashimaYXiaDCuiFHydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulinInt J Nanomedicine201163049305622162661
   PubMed Web of Science ®Google Scholar
• MillerJMDahanAGuptaDVargheseSAmidonGLEnabling the intestinal absorption of highly polar antiviral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivirMol Pharm2010741223123420536260
   PubMed Web of Science ®Google Scholar
• PangeniRChoiSWJeonOCByunYParkJWMultiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluationInt J Nanomed20161163796399
   PubMed Web of Science ®Google Scholar
• De La TorrePTorradoSTorradoSPreparation, dissolution and characterization of praziquantel solid dispersionsChem Pharm Bull1999471116291633
   Web of Science ®Google Scholar
• DahanABeigAIoffe-DahanVAgbariaRMillerJMThe twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membraneAAPS J201315234735323242514
   PubMed Web of Science ®Google Scholar
• FrankKJRosenblattKMWestedtUAmorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation vs. apparent solubility enhancementInt J Pharm20124371–228829322951865
   PubMed Web of Science ®Google Scholar
• BeigAMillerJMDahanAAccounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorptionEur J Pharm Biopharm201281238639122387337
   PubMed Web of Science ®Google Scholar
• MoesJKoolenSHuitemaASchellensJBeijnenJNuijenBDevelopment of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxelEur J Pharm Biopharm2013831879423085332
   PubMed Web of Science ®Google Scholar
• PangeniRSharmaSMustafaGAliJBabootaSVitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson’s disease by reducing oxidative stressNanotechnology20142548113
   Web of Science ®Google Scholar
• TadrosTIzquierdoPEsquenaJSolansCFormation and stability of nano-emulsionsAdv Colloid Interface Sci2004108–109303318
   Google Scholar
• GaoYWangYMaYFormulation optimization and in situ absorption in rat intestinal tract of quercetin-loaded microemulsionColloids Surf B Biointerfaces200971230631419375897
   PubMed Web of Science ®Google Scholar
• BaliVAliMAliJStudy of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibeColloids Surf B Biointerfaces201076241042020042320
   PubMed Web of Science ®Google Scholar
• SilvaHDCerqueiraMAVicenteAAInfluence of surfactant and processing conditions in the stability of oil-in-water nanoemulsionsJ Food Eng20151678998
   Web of Science ®Google Scholar
• PatelARVaviaPRPreparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrateAAPS J200793E344E35218170981
   PubMed Web of Science ®Google Scholar
• HuFQWuXLDuYZYouJYuanHCellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicinEur J Pharm Biopharm200869111712517997293
   PubMed Web of Science ®Google Scholar
• MelguizoCCabezaLPradosJEnhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticlesDrug Des Devel Ther2015964336444
   PubMed Web of Science ®Google Scholar
• MrestaniYBretschneiderBHartlANeubertRHIn-vitro and in-vivo studies of cefpirom using bile salts as absorption enhancersJ Pharm Pharmacol200355121601160614738584
   PubMed Web of Science ®Google Scholar
• HofmannAFMyselsKJBile salts as biological surfactantsColloids and Surfaces1987301145173
   Google Scholar
• GuptaSKesarlaROmriAFormulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systemsISRN Pharm20132013116
   Google Scholar
• RaimondiFSantoroPBaroneMVBile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activationAm J Physiol Gastrointest Liver Physiol20082944G906G91318239063
   PubMed Web of Science ®Google Scholar
• SeeligAGerebtzoffGEnhancement of drug absorption by noncharged detergents through membrane and P-glycoprotein bindingExpert Opin Drug Metab Toxicol20062573375217014392
   PubMed Web of Science ®Google Scholar
• FofariaNMQhattalHSLiuXSrivastavaSKNanoemulsion formulations for anti-cancer agent piplartine – characterization, toxicological, pharmacokinetics and efficacy studiesInt J Pharm20164981–2122226642946
   PubMedGoogle Scholar
• SpositoPAMazzetiALde Oliveira FariaCRavuconazole self-emulsifying delivery system: in vitro activity against trypanosoma cruzi amastigotes and in vivo toxicityInt J Nanomedicine2017123785379928553114
   PubMed Web of Science ®Google Scholar
• ShaXYanGWuYLiJFangXEffect of self-microemulsifying drug delivery systems containing labrasol on tight junctions in Caco-2 cellsEur J Pharm Sci200524547748615784337
   PubMed Web of Science ®Google Scholar
• BalakrishnanAPolliJEApical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug targetMol Pharm20063322323016749855
   PubMed Web of Science ®Google Scholar
• LazaridisKNPhamLTietzPRat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporterJ Clin Invest199710011271427219389734
   PubMed Web of Science ®Google Scholar
• ParkJWKimSKAl-HilalTAJeonOCMoonHTByunYStrategies for oral delivery of macromolecule drugsBiotechnol Bioprocess Eng20101516675
   Web of Science ®Google Scholar
• JeonOCHwangSRAl-HilalTAOral delivery of ionic complex of ceftriaxone with bile acid derivative in non-human primatesPharm Res201330495996723292220
   PubMed Web of Science ®Google Scholar
• ChoudhuryHGorainBKarmakarSImprovement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platformInt J Pharm20144601–213114324239580
   PubMedGoogle Scholar
• DaiWGDongLCSongYEnhanced bioavailability of poorly absorbed hydrophilic compounds through drug complex/in situ gelling formulationInt J Pharm20134571637024004566
   PubMedGoogle Scholar
• WanKSunLHuXNovel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcuminInt J Pharm20165041–2808827034002
   PubMedGoogle Scholar
• YanezJARemsbergCMSayreCLForrestMLDaviesNMFlip-flop pharmacokinetics – delivering a reversal of disposition: challenges and opportunities during drug developmentTher Deliv20112564367221837267
   PubMedGoogle Scholar
• WuCYBenetLZPredicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification systemPharm Res2005221112315771225
   PubMed Web of Science ®Google Scholar
• ForsgardRAKorpelaRStenmanLKOsterlundPHolmaRDeoxycholic acid induced changes in electrophysiological parameters and macromolecular permeability in murine small intestine with and without functional enteric nervous system plexusesNeurogastroenterol Motil20142681179118724954839
   PubMed Web of Science ®Google Scholar
• GaoFZhangZBuHNanoemulsion improves the oral absorption of candesartan cilexetil in rats: performance and mechanismJ Control Release2011149216817420951749
   PubMed Web of Science ®Google Scholar
• HerediaRMBoerisPSBiasuttiMALopezGAPaulucciNSLucchesiGICoordinated response of phospholipids and acyl components of membrane lipids in Pseudomonas putida A (ATCC 12633) under stress caused by cationic surfactantsMicrobiology2014160Pt 122618262625280753
   PubMedGoogle Scholar